Eton Pharmaceuticals Inc (ETON): Next-Year EPS Estimate 136.45%
As of 2026-06-11, Eton Pharmaceuticals Inc (ETON) has a next-year EPS growth estimate of 136.45%.
On 2026-05-21, analyst consensus for ETON's next-year EPS growth shifted from 136.34% to 136.45% — a positive change of 0.11 percentage points. The revised estimate has been sustained across 16 subsequent trading sessions. Current-year growth is projected at 129.34%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 136.45%
- EPS growth this year
- 129.34%
- EPS next quarter (est)
- $0.15
- Last price
- $32.11
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 136.45% | 129.34% | $0.15 | $32.11 |
| 2026-06-10 | 136.45% | 129.34% | $0.15 | $30.95 |
| 2026-06-09 | 136.45% | 129.34% | $0.15 | $30.53 |
| 2026-06-08 | 136.45% | 129.34% | $0.15 | $29.95 |
| 2026-06-07 | 136.45% | 129.34% | $0.15 | $29.13 |
| 2026-06-04 | 136.45% | 129.34% | $0.15 | $28.90 |
| 2026-06-03 | 136.45% | 129.34% | $0.15 | $27.61 |
| 2026-06-02 | 136.45% | 129.34% | $0.15 | $27.40 |
| 2026-06-01 | 136.45% | 129.34% | $0.15 | $28.68 |
| 2026-05-31 | 136.45% | 129.34% | $0.15 | $30.45 |
| 2026-05-28 | 136.45% | 129.34% | $0.15 | $31.86 |
| 2026-05-27 | 136.45% | 129.34% | $0.15 | $32.40 |
| 2026-05-26 | 136.45% | 129.34% | $0.15 | $31.29 |
| 2026-05-25 | 136.45% | 129.34% | $0.15 | $32.59 |
| 2026-05-24 | 136.45% | 129.34% | $0.15 | $32.59 |
| 2026-05-21 | 136.45% | 129.34% | $0.15 | $35.00 |
| 2026-05-20 | 136.34% | 129.29% | $0.15 | $34.45 |
| 2026-05-19 | 136.34% | 129.29% | $0.15 | $32.89 |
| 2026-05-18 | 136.34% | 129.29% | $0.15 | $32.49 |
| 2026-05-17 | 136.34% | 129.29% | $0.15 | $30.26 |
| 2026-05-14 | 118.54% | 141.43% | $0.11 | $29.96 |
| 2026-05-13 | 118.54% | 141.43% | $0.11 | $30.63 |
| 2026-05-12 | 118.54% | 141.43% | $0.11 | $29.71 |
| 2026-05-11 | 118.54% | 141.43% | $0.11 | $29.84 |
| 2026-05-10 | 118.54% | 141.43% | $0.11 | $29.65 |
| 2026-05-07 | 118.54% | 141.43% | $0.11 | $31.02 |
| 2026-05-06 | 118.54% | 141.43% | $0.11 | $30.15 |
| 2026-05-05 | 106.72% | 155.24% | $0.11 | $30.38 |
| 2026-05-04 | 106.72% | 155.24% | $0.11 | $30.16 |
| 2026-05-03 | 109.24% | 137.14% | $0.11 | $28.90 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Eton Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Eton Pharmaceuticals Inc (ETON) has a next-year EPS growth estimate of 136.45%, based on analyst consensus.
When was the latest EPS estimate revision for ETON?▾
The most recent revision occurred on 2026-05-21, when analysts adjusted the next-year EPS growth estimate from 136.34% to 136.45%.
What sector and industry does Eton Pharmaceuticals Inc belong to?▾
Eton Pharmaceuticals Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ETON appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Eton Pharmaceuticals Inc (ETON) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports